To prohibit the use of funds to implement regulations regarding the removal of essential-use designation for epinephrine used in oral pressurized metered-dose inhalers.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Roll call votes on amendments in Senate: Amendment SA 763 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 191.
November 1, 2011
View full timeline
Roll call votes on amendments in Senate: Amendment SA 763 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 191.
November 1, 2011
Senate amendment not agreed to: Amendment SA 763 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 191.
November 1, 2011
Considered by Senate. (consideration: CR S6932, S6934)
November 1, 2011
Amendment SA 763 not agreed to in Senate by Yea-Nay Vote. 44 - 54. Record Vote Number: 191.
November 1, 2011
Considered by Senate. (consideration: CR S6791)
October 20, 2011
Senate amendment proposed (on the floor): Amendment SA 763 proposed by Senator Blunt for Senator DeMint to Amendment SA 738.
October 19, 2011
Amendment SA 763 proposed by Senator Blunt for Senator DeMint to Amendment SA 738. (consideration: CR S6751; text: CR S6751) To prohibit the use of funds to implement regulations regarding the removal of essential-use designation for epinephrine used in oral pressurized metered-dose inhalers.
October 19, 2011
Senate amendment submitted
October 17, 2011
Votes
1 roll call on this amendment
Text
Submitted
SA 763. Mr. DeMINT submitted an amendment intended to be proposed by him to the bill H.R. 2112, making appropriations for Agriculture, Rural Development, Food and Drug Administration, and Related Agencies programs for the fiscal year ending September 30, 2012, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place, insert the following: Sec. __. None of the funds made available by this Act may be used to implement the final rule entitled ``Use of Ozone- Depleting Substances; Removal of Essential-Use Designation (Epinephrine)'' (73 Fed. Reg. 69532 (November 19, 2008)). ______